Overzicht van nieuwe geneesmiddelen (ATC-codes) in 2021 met de vergoeding per jaar
- Raming voor de totale Zvw-populatie
| Introductiejaar | ATC-code | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| 2021 | A16AX16 Givosiran | 288.612 | 2.218.286 | 1.975.462 | 2.715.803 |
| B02BX08 Avatrombopag | 10.693 | 245.207 | 1.083.460 | 1.865.350 | |
| J05AJ04 Cabotegravir | 46.128 | 1.969.628 | 4.450.214 | 5.107.585 | |
| J07BK03 Zoster gezuiverd antigeen | 127.841 | 1.101.317 | 2.173.285 | 2.064.427 | |
| L04AE03 Siponimod | 1.364.136 | 3.412.209 | 3.915.420 | 3.542.288 | |
| M05BX06 Romosozumab | 778.317 | 2.852.013 | 5.629.199 | 8.635.648 | |
| M09AX03 Ataluren | 9.205 | 4.811.616 | 4.934.175 | 3.660.548 | |
| N02CD01 Erenumab | 562.853 | 7.030.763 | 8.877.070 | 9.884.704 | |
| N02CD02 Galcanezumab | 1.029.076 | 6.643.213 | 8.399.547 | 9.100.982 | |
| N02CD03 Fremanezumab | 352.565 | 5.351.650 | 8.978.726 | 13.395.264 | |
| R03AK14 Indacaterol met mometason | 9.857 | 28.721 | 37.737 | 43.558 | |
| R03AL11 Formoterol met glycopyrroniumbromide en budesonide | 77.430 | 366.573 | 852.427 | 1.499.357 | |
| V03AE10 Natriumzirconiumcyclosilicaat | 102.990 | 301.267 | 548.374 | 593.984 | |
| Totaal | 4.759.703 | 36.332.462 | 51.855.096 | 62.109.498 |